NOWS the Time to Reduce NAS: A guide for managing newborns affected by opioids

Posted on November 30, 2022

Pharmacist Academic Detailer Speaker:
Please visit https://academicdetail.pharmacy.uic.edu/speakers_disclosures/ for a list of potential speakers.

Disclosure (s): For the latest disclosure information please visit https://academicdetail.pharmacy.uic.edu/speakers_disclosures/

The speakers, planning committee members, and reviewers who contributed to this program have no relevant financial conflicts of interest to disclose unless noted below.

  • Speaker, Dr. Chintan Patel has stock ownership with companies: Abbvie, Caladrius Biosciences Inc, Clover Health Investments Corp, Diffusion Pharmaceuticals Inc, Dynavax Technologies Corp, Gilead Sciences Inc, Glasko Smith Kline, Haleon, lmmunocellular Therapeutics, Motus GI Holdings Inc, Novabay Pharmaceuticals Inc, Novavax Inc, Ocugen Inc, Pfizer Inc, Protalix Biotherapeutics Inc, PuImatrix Inc, Quince Therapeutics Inc, Salarius Pharmaceuticals inc, Synthetic Biologics Inc, and Vaccinex Inc.
  • Speaker, Dr. Stewart Chung has stock ownership with companies Takeda and Silo Pharmaceutical.
  • Speaker, Dr. Judith Jakuszewski has stock ownership with Pfizer.

All relevant financial relationships listed for the above speakers have been mitigated.

Type of Activity: Knowledge-based

Learning Objectives:

  • Describe the symptoms associated with Neonatal Opioid Withdrawal Syndrome (NOWS)
  • Discuss the non-pharmacologic and pharmacologic treatment options for NOWS
Target Audience: Nurses Fee: Free
Release Date: October 1, 2022 Expiration Date: February 17, 2024
Estimated time to complete: 0.5 hours CNE: 0.5 contact hours of CNE

Go to activity

CNE logo
UI Health is approved as a provider of nursing continuing professional development by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (OBN-001-91). In regard to successful completion and contact hours being awarded: 0.5 Continuing Nursing Education contact hours will be awarded to participants who attend the entire duration of the activity and complete the online evaluation following the activity. Advanced practice nurses may count a total of 0.5 contact hours for the pharmacotherapeutic educational requirement.

How to Earn Credit:
Participants must complete the activity as described above in the Continuing Education Statements by attending the entire academic detailing session, completing a pre and post-test, and successfully submitting an activity evaluation. A certificate of completion or uploading of CPE credits to CPE Monitor will be issued after all requirements as described are completed.

Hardware/Software and Internet Requirements can be found at https://cemedicine.uic.edu/online-activities/requirements/.

Provider Contact Information:
For general information please call the Office of Continuing Education and Meeting Services toll-free at (866) PHARM-CE (866-742-7623) or send an e-mail to: pharmce@uic.edu. Copyright © 2022– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy

Modified on July 13, 2023